Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Exchange Rate Effect (2017 - 2025)

Vanda Pharmaceuticals (VNDA) has disclosed Exchange Rate Effect for 9 consecutive years, with $20000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 109.9% to $20000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23000.0 through Dec 2025, up 114.11% year-over-year, with the annual reading at $23000.0 for FY2025, 114.11% up from the prior year.
  • Exchange Rate Effect hit $20000.0 in Q4 2025 for Vanda Pharmaceuticals, up from -$180000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $183000.0 in Q4 2022 to a low of -$202000.0 in Q4 2024.
  • Historically, Exchange Rate Effect has averaged $4050.0 across 5 years, with a median of $3000.0 in 2021.
  • Biggest five-year swings in Exchange Rate Effect: tumbled 941.67% in 2021 and later skyrocketed 993.33% in 2025.
  • Year by year, Exchange Rate Effect stood at -$101000.0 in 2021, then soared by 281.19% to $183000.0 in 2022, then fell by 18.03% to $150000.0 in 2023, then crashed by 234.67% to -$202000.0 in 2024, then soared by 109.9% to $20000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for VNDA at $20000.0 in Q4 2025, -$180000.0 in Q3 2025, and $134000.0 in Q2 2025.